Study links GLP-1, other diabetes drugs to lower risk of Alzheimer’s and dementia

The new study could potentially pave the way for new strategies to prevent dementia using drugs that are already approved and on the market.

The new study could pave the way for new strategies to prevent dementia using drugs already on the market.


Stay informed

Sign up for The Daily Consumer

Get the latest on recalls, scams, lawsuits, and more

    By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

    Thanks for subscribing.

    You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

    Was this article helpful?

    Share your experience about ConsumerAffairs

    Was this article helpful?

    Share your experience about ConsumerAffairs